Cancer Research UK logo.
SearchDonate
  • Search

Penile cancer risk

Older age is the main risk factor for cancer. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors.

This page covers other factors with the best evidence of an association with cancer risk; this list is not exhaustive.

See our other pages for general information about cancer, or ways to reduce your risk.

More penile cancer statistics

Incidence

Mortality

Survival

Risk

Statistics by cancer type

View our latest cancer statistics including key stats, in-depth explanations and raw data on cancer incidence, mortality, survival, risk, and diagnosis and treatment.

View full A-Z cancer statistics

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Local cancer statistics

Go to local cancer statistics - search profiles by area, constituency or health board in the UK.

Go to devolved nations overview for an overview of Wales, Scotland or Northern Ireland.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
 Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

  • Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].

  • Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.

  • Graphics (when reused unaltered): Credit: Cancer Research UK.

  • Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research. Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ.

Donate online

Newsletter

Stay up to date by signing up to our cancer statistics and intelligence newsletter.

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used.

Find out more about the sources which are essential for our statistics

References

  1. Arrow return up icon

    Lifetime risk estimates calculated by the Cancer Intelligence Team at Cancer Research UK 2023.

  2. Arrow return up icon

    Estève J, Benhamou E, Raymond L. Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ. 1994;(128):1-302.

  3. Arrow return up icon
  4. Arrow return up icon

    International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 122*. Accessed August 2018.

  5. Arrow return up icon
  6. Arrow return up icon

    Backes DM, Kurman RJ, Pimenta JM, et al. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009 May;20(4):449-57.

  7. Arrow return up icon

    Miralles-Guri C, Bruni L, Cubilla AL, et al. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009 Oct;62(10):870-8.

  8. Arrow return up icon

    Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015 Apr 29;107(6):djv086.

  9. Arrow return up icon

    Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis Lancet 2007;370(9581):59-67.

  10. Arrow return up icon

    Olesen TB, Munk C, Christensen J, et al. Human papillomavirus prevalence among men in sub-Saharan Africa: a systematic review and meta-analysis. Sex Transm Infect. 2014 Sep;90(6):455-62.

  11. Arrow return up icon

    Madsen BS, van den Brule AJ, Jensen HL, et al. Risk factors for squamous cell carcinoma of the penis--population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2683-91.

  12. Arrow return up icon

    Tsen HF, Morgenstern H, Mack T, et al. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 2001 Apr;12(3):267-77.

  13. Arrow return up icon

    Brinton LA, Li JY, Rong SD, Huang S, et al. Risk factors for penile cancer: results from a case-control study in China. Int J Cancer. 1991 Feb 20;47(4):504-9.

  14. Arrow return up icon

    Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005 Sep 10;116(4):606-16.

  15. Arrow return up icon

    Larke NL, Thomas SL, dos Santos Silva I, et al. Male circumcision and penile cancer: a systematic review and meta-analysis. Cancer Causes Control. 2011 Aug;22(8):1097-110. doi: 10.1007/s10552-011-9785-9.